AbbVie Inc (NYSE:ABBV) will be reporting its third-quarter earnings on Wednesday. Wall Street expects $2.92 in EPS and $14.28 billion in revenues as the company reports before market hours. Ahead of ...

If you’ve ever looked at a trading platform and seen a chart filled with rectangles and vertical lines, you’ve already encountered a candlestick chart — even if you didn’t realize it. These colorful ...

AbbVie presents a bullish outlook supported by positive earnings, a strong dividend, and robust technical indicators. ABBV beat Q3 earnings and revenue expectations, raised full-year EPS guidance, and ...

AbbVie shares are nearing $200, likely facing resistance and a potential pullback to test support between $175 and $185. Despite strong dividends and share buybacks, AbbVie’s higher P/E ratio and ...